Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Redwire Corporation (RDW) Price & Performance

AbCellera Biologics IncTrade
Redwire CorporationTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Redwire Corporation — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Redwire Corporation trades at $13.51 (market cap $3.38B). The key difference: AbCellera Biologics Inc and Redwire Corporation are close in size by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Redwire Corporation nearer its low. Which is the better fit depends on your goals.

ABCLRDW
Market Cap
$2.99B$3.38B
Sector
HealthTechnology
52-Week High
$9.76$25.90
52-Week Low
$2.78$5.06
Enterprise Value
$2.58B$2.91B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Redwire Corporation

Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.

Read more on RDW